Additionally, overexpression of β-catenin in these cells also partially reversed the paclitaxel sensitivity, demonstrating that both of PKM2 and β-catenin are involved in miR-152-induced paclitaxel treatment response and PKM2 played a more sensitive role in paclitaxel resistance of breast cancer (Fig. 3). Here, PKM is linked to breast carcinoma.